Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Oatly has launched climate footprint labels on its products in North America.
British energy giant BP predicts that fossil fuels as a primary energy source will decline from 80 percent in 2019 to between 55 and 20 percent in 2050.
First responders fired after video of police beating Tyre Nichols was released, 10 people show in Lanland, Fla. and winter storm is causing travel troubles. Here is everything you Need2Know for January 31, 2023.
Los Angeles-based FluentPet has developed a series of tiles it claims help four-legged companions communicate with their humans.
The World Health Organization chief says the coronavirus remains a global health emergency.
The Food and Drug Administration is changing its policy to make it easier for gay men to donate blood.
Blue Origin is sending an all-female crew into orbit next year, according to The Wall Street Journal.
Jeff Bezos' girlfriend is leading an all-female space mission aboard a Blue Origin spacecraft.
The Food and Drug Administration is raising concerns about the long-term effects of CBD.
CVS and Walmart are cutting back pharmacy hours due to a shortage of pharmacists.
